BIOVIA provides insight into druggability and intelligence on investigational drugs by providing access to one of the world’s leading collections of bioactivity data.
Understand the competitive space for biologically active molecules and develop structure-activity relationships (SARs) using one of the most authoritative and current collections of bioactivity findings for newly launched or developmental drugs.
Comprehensive Medicinal Chemistry (CMC)
Validate new pharmacophores and build structure-based calculators and SARs with the definitive reference on compounds used or studied as medicinal agents in humans.
Anticipate adverse effects based upon chemical structure and link structure with metabolism information in the largest structure-searchable compendium of compounds with reported in vivo and in vitro toxic properties. The Toxicity Database also includes the Registry of Toxic Effects of Chemical Substances (RTECS®) database—a comprehensive collection of basic toxicity information for over 160,000 chemical substances from pharmaceuticals to foodstuffs.